Clinical Trial Update: The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for an elderly patient individualized chemotherapy approach in stage IV non-small cell lung cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Turin, Italy | Conditions: Stage IV, NSCLC, Lung Neoplasms | Phase 3 | Status: UNKNOWN